ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

AACR Receives Record Number of Abstracts

January 27, 1989

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998